Globe Life (GL) Projected to Post Earnings on Wednesday

Globe Life (NYSE:GLGet Free Report) is anticipated to post its Q2 2025 quarterly earnings results after the market closes on Wednesday, July 23rd. Analysts expect the company to announce earnings of $3.27 per share and revenue of $1.50 billion for the quarter. Globe Life has set its FY 2025 guidance at 13.450-14.050 EPS.

Globe Life (NYSE:GLGet Free Report) last issued its quarterly earnings data on Wednesday, April 30th. The company reported $3.07 earnings per share for the quarter, missing analysts’ consensus estimates of $3.24 by ($0.17). Globe Life had a return on equity of 21.44% and a net margin of 18.33%. The company had revenue of $1.48 billion for the quarter, compared to analysts’ expectations of $1.49 billion. During the same quarter last year, the company earned $2.78 earnings per share. The company’s revenue for the quarter was up 4.5% compared to the same quarter last year. On average, analysts expect Globe Life to post $14 EPS for the current fiscal year and $15 EPS for the next fiscal year.

Globe Life Trading Down 2.3%

Globe Life stock opened at $117.87 on Wednesday. The stock has a 50-day moving average of $120.88 and a two-hundred day moving average of $121.36. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.07 and a current ratio of 0.07. Globe Life has a one year low of $86.10 and a one year high of $133.76. The stock has a market cap of $9.73 billion, a PE ratio of 9.59 and a beta of 0.56.

Globe Life Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Thursday, July 3rd will be issued a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.92%. The ex-dividend date is Thursday, July 3rd. Globe Life’s dividend payout ratio (DPR) is 8.79%.

Insider Activity at Globe Life

In other Globe Life news, CEO Frank M. Svoboda sold 6,019 shares of the business’s stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $122.51, for a total value of $737,387.69. Following the completion of the sale, the chief executive officer owned 31,298 shares of the company’s stock, valued at $3,834,317.98. The trade was a 16.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.97% of the stock is currently owned by company insiders.

Institutional Trading of Globe Life

A number of large investors have recently made changes to their positions in GL. Acadian Asset Management LLC bought a new position in Globe Life in the first quarter valued at approximately $322,000. Empowered Funds LLC bought a new position in Globe Life in the first quarter valued at approximately $428,000. NewEdge Advisors LLC grew its stake in Globe Life by 368.1% in the first quarter. NewEdge Advisors LLC now owns 6,806 shares of the company’s stock valued at $897,000 after purchasing an additional 5,352 shares in the last quarter. Focus Partners Wealth boosted its stake in shares of Globe Life by 8.3% during the 1st quarter. Focus Partners Wealth now owns 8,559 shares of the company’s stock worth $1,127,000 after acquiring an additional 656 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Globe Life by 6.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company’s stock worth $1,237,000 after acquiring an additional 607 shares during the period. Institutional investors own 81.61% of the company’s stock.

Wall Street Analyst Weigh In

GL has been the topic of a number of research analyst reports. Morgan Stanley set a $127.00 target price on Globe Life and gave the company an “equal weight” rating in a research report on Monday. Wall Street Zen upgraded Globe Life from a “hold” rating to a “buy” rating in a research report on Friday, May 16th. Piper Sandler reduced their target price on Globe Life from $152.00 to $147.00 and set an “overweight” rating on the stock in a research report on Friday, May 2nd. Truist Financial initiated coverage on Globe Life in a research report on Tuesday. They issued a “buy” rating and a $150.00 target price on the stock. Finally, JPMorgan Chase & Co. lifted their target price on Globe Life from $145.00 to $160.00 and gave the company an “overweight” rating in a research report on Tuesday, July 8th. Three research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $143.82.

Read Our Latest Research Report on GL

About Globe Life

(Get Free Report)

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

Featured Articles

Earnings History for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.